SPENCER JOHNSON: Open Payments
NPI 1063579779 · TEMPLE HILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 57 payments from 9 companies in 2025. Trend: 2023 $181 · 2024 $783 · 2025 $1,137
Food & beverage: $1,113Education: $24
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $250 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $238 |
| Alkermes, Inc. | 13 | $230 |
| Vanda Pharmaceuticals Inc. | 8 | $136 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| Lundbeck LLC | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
Products named: COBENFY, CAPLYTA, ARISTADA, REXULTI, FANAPT, INGREZZA, HETLIOZ, ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
